South Korea Drug Development Trends – Strategic Intelligence

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

$1495

South Korea has become a significant player in the global pharmaceutical industry and drug development space, fueled by its advanced healthcare system, growing pharmaceutical sector, strong research infrastructure, and government-backed initiatives to support innovation. The country has been increasingly focusing on innovation and cutting-edge technologies, such as CGTs, as well as development of advanced therapies such as ADCs, mRNA-based treatments, and CAR-T therapies. As a result, South Korea is establishing itself as a growing hub for clinical trials and drug development, attracting global attention and investment.

In this report, GlobalData explores the key metrics shaping South Korea’s drug development landscape, including approved and pipeline drugs, the clinical trials landscape, as well as deal-making trends, to assess its impact on the global pharmaceutical industry.

Key Findings of the report include:
– South Korea’s drug development is growing, focusing on early R&D and CGTs.
– South Korea is advancing therapies like ADCs, mRNA, and CAR-T.
– The rise in drug approvals in recent years highlights South Korea’s strong regulatory support.
– South Korea’s pharma deals have slowed in recent years, but strategic alliances remain key.
– Phase I clinical trials have become the focus in South Korea, representing the largest category.

Scope

Study objectives

To analyze South Korea’s drug development activities, including the most promising agents

To explore the growth of CAR-T cell and ADC therapies in this market

To examine the role of South Korea’s regulatory environment in accelerating the approval of innovative therapies

To assess the growth in clinical trials conducted in South Korea

To analyze deal-making activity trends

Report design

The data presented in this report is taken from GlobalData’s drug, clinical trials, and deals databases

The sources were accessed and data was derived in February 2025

Reasons to Buy

Gain insights into South Korea’s rapidly evolving drug development landscape, including key innovative therapies.

Understand the growth trajectory and market potential of CAR-T cell and ADC therapies in South Korea.

Explore the impact of South Korea’s regulatory reforms on the accelerated approval.

Stay informed on the increasing number of clinical trials conducted in South Korea.

Identify emerging trends in deal-making activities and partnership opportunities.

Table of Contents

Table of Contents (PowerPoint Deck)

1 Executive Summary

1.1 Executive Summary

2 Introduction

2.1 Study Objectives and Report Design

3. Drug Development Trends

3.1 South Korea Expanding Footprint in Global Drug Development

3.2 Companies Based in South Korea Making Strides in Drug Development Activity

3.3 Drugs by Development Stage: South Korea vs. US – 2020–25 (YDT)

3.4 The Most Drug Development Activity Is in Oncology, Both in the US and in South Korea

3.5 ADC Therapies and mRNA Therapies Dominate the Technological Advancement for Drug Development in South Korea

3.6 Top 10 Companies in South Korea Have About 44% of Their Pipeline Assets in Clinical-Stage

3.7 Surge in Approvals in 2023–24 Can Be Attributed to Strong Support from South Korea’s Regulatory Environment

3.8 Global Sales Forecast from South Korean Companies

3.9 Pharma Deal Tends in South Korea: 2015–25 (YTD)

3.10 Drug Approvals in South Korea (last 6 months) (1/2)

3.11 Drug Approvals in South Korea (last 6 months) (2/2)

3.12 Deal Activity by South Korean Companies: 2020–25 (YTD)

3.13 Company-Sponsored Clinical Trials Conducted in South Korea vs. US by Trial Start Year

3.14 Company-Sponsored South Korea Trials by Trial Start Year & Trial Phase

3.15 Sponsor Headquarters for Single-Country & Multinational Trials in South Korea

3.16 Single-Country & Multinational Company-Sponsored Trials by Trial Start Year

4 Summary of Key Findings

4.1 Key Takeaways

5 Appendix

5.1 Abbreviations

5.2 Related Reports

6 About the Authors

6.1 About the Authors

7 Contact Us

7.1 Contact US

7.2 A global network of offices

7.3 About GlobalData

7.4 A Connected Platform for a Dynamic World

7.5 Contact Us

South Korea Drug Development Trends – Strategic Intelligence thematic reports
Currency USD
$1,495

Can be used by individual purchaser only

$2,990

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

See what our customers are saying
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Pharmaceuticals
New
Bio/Pharmaceutical Outsourcing Report, September 2026
$2,950 | October 2026
Pharmaceuticals
New
IDWeek 2026: Pre-Conference Coverage
$1,500 | October 2026
Pharmaceuticals
New
Gonorrhea: Market View, Current and Future Competitive Landscape
$3,495 | October 2026
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at South Korea Drug Development Trends – Strategic Intelligence in real time.

  • Access a live South Korea Drug Development Trends – Strategic Intelligence dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.